Gene expression and cell turnover in human renal dysplasia

Histology and Histopathology

Volumn 15, Issue 1, 2000, Pages 159-166

  Woolf, A S ^a   Winyard, Paul J D ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; BCL2; Cyst epithelium; Galectin 3; PAX28 Proliferation; WT1

Indexed keywords

GALECTIN 3; GROWTH FACTOR; PROTEIN BCL 2; STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; DEREGULATION; GENE EXPRESSION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY EPITHELIUM; MESENCHYME CELL; PROTEIN LOCALIZATION; REVIEW;

ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL DIVISION; CHILD; DNA-BINDING PROTEINS; GALECTIN 3; GENE EXPRESSION; GENES, BCL-2; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PAX2 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 0033971350     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Attar R., Quinn F., Winyard P.J.D., Mouriquand P.D.E., Foxall P., Hanson M.A. and Woolf A.S. (1998). Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys. Am. J. Pathol. 152, 1225-1235.
2. Bao Q. and Hughes R.C. (1995). Galectin-3 expression and effects on cyst enlargement and tubulogenesis in kidney epithelial MDCK cells cultured in three dimensional matrices in vitro. J. Cell Sci. 108, 2791-2800.
3. Bernstein J. (1993). Glomerulocystic kidney disease: nosological considerations. Ped. Nephrol. 7, 464-470.
4. Bravo R., Frank R., Blundell P.A. and MacDonald-Bravo H, (1987). Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326, 515-517.
5. Cale C.M., Klein N.J., Morgan C. and Woolf A.S. (1998). Tumour necrosis factor-a inhibits epithelial differentiation and morphogenesis in the mouse metanephric kidney in vitro. Int. J. Dev. Biol. 42, 663-674.
6. Cale C.M., Klein N.J., Winyard P.J.D. and Woolf A.S. (1999). Inflammatory mediators in human renal dysplasia. Neph. Dial. Transpl. (In press).
7. Coles H.S.R., Burne J.F. and Raff M.C (1993). Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118, 777-784.
8. Dressier G.R., Wilkinson J.E., Rothenpieler U.W., Patterson L.T., Williams-Simons L. and Westphal H. (1993). Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362, 65-67.
9. Eccles M.R., Wallis L.J., Fidler A.E., Spurr N.K., Goodfellow P.J. and Reeve A.E. (1992). Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Diff. 3, 279-289.
10. Gavrelli Y., Sheman Y. and Ben-Sassoon S.A. (1992). Identification of programmed cell death in situ via specific labeling of DNA fragmentation. J. Cell Biol. 119, 493-501.
11. Gnarra J.R. and Dressier G.R. (1995). Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55, 4092-4098.
12. Granata C., Wang Y., Puri P., Tanaka K. and O'Brian D.S. (1997). Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis. Br. J. Urol. 80, 140-144.
13. Homsy Y.L., Anderson J.H., Oudjhane K. and Russo P. (1997). Wilms tumor and multicystic dysplastic kidney disease. J. Urol. 158, 2256-2259.
14. Kolatsi-Joannou M., Moore R., Winyard P.J.D. and Woolf A.S. (1997). Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis. Pediatr. Res. 41, 657-665.
15. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D. and Jaenisch R. (1993). WT-1 is required for early kidney development. Cell 74, 679-691.
16. Liapis H., Nag M. and Steinhardt G. (1994). Effects of experimental ureteral obstruction on platelet-derived growth factor-A and type I procollagen expression in fetal metanephric kidneys. Pediatr. Nephrol. 8, 548-554.
17. Liapis H., Yu H., Flath A. and Steinhardt G.F. (1997). Increased expression of platelet-derived growth factor A and collagenous matrix proteins in congenital multicystic renal dysplasia. Nephron 76, 161-170.
18. Matsell D.G., Bennett T., Armstrong R.A., Goodyer P., Goodyer C. and Man V.K.M. (1997). Insulin-like growth factor and IGF binding protein gene expression in multicystic renal dysplasia. J. Am. Soc. Nephrol. 8, 85-94.
19. Maulbecker C.C. and Gruss P. (1993). The oncogenic potential of Pax genes. EMBO J. 12, 2361-2367.
20. Mesrobian H.G.J., Rushton H.G. and Bulas D. (1993). Unilateral renal agenesis may result from in utero regression of multicystic dysplasia. J. Urol. 150, 793-794.
21. Noia G., Masini L., De Santis M. and Caruso A. (1996). The impact of invasive procedures on prognostic, diagnostic and therapeutic aspects or urinary tract anomalies. In: Neonatal nephrology in progress. Cataldi L., Fanos V. and Simeoni U. (eds). Agora. Lecce, Italy. pp 67-84.
22. Potter E.L. (1972). Normal and abnormal development of the kidney. Year Book Medical Publishers Inc. Chicago.
23. Risdon R.A. and Woolf A.S. (1998a). Chapter 26. Developmental defects and cystic diseases of the kidney. In: Heptinstall's pathology of the Kidney. 5th edition. Jennette J.C., Olson J.L., Schwartz M.M. and Silva F.G. (eds). Lippincott-Raven, Philadelphia-New York. USA. pp 1149-1206.
24. Risdon R.A. and Woolf A.S. (1998b). Chapter 2. Development of the kidney. In: Heptinstall's pathology of the kidney. 5th edition. Jennette J.C., Olson J.L., Schwartz M.M. and Silva F.G. (eds). Lippincott-Raven, Philadelphia-New York, USA. pp 67-84.
25. Rogers S.A., Ryan G. and Hammerman M. (1991). Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro. J. Cell Biol. 113, 1447-1453.
26. Stuart E.T., Haffner R., Oren M. and Gruss P. (1995). Loss of p53 function through PAX-mediated transcriptional repression. EMBO J. 14, 5638-5645.
27. Torres M., Gomez-Pardo E., Dressier G.R. and Gruss P. (1995). Pax-2 controls multiple steps of urogenital development. Development 121, 4057-4065.
28. Veis D.J., Sorenson C.M., Shutter J.R. and Korsmeyer S.J. (1994). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75, 229-240.
29. Warady B.A., Hebert D., Sullivan E.K., Alexander S.R. and Tejani A. (1997). Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Ped. Nephrol. 11, 49-64.
30. Winyard P.J.D., Risdon R.A., Sams V.R., Dressier G.R. and Woolf A.S. (1996a). The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J. Clin. Invest. 98, 451-459.
31. Winyard P.J.D., Nauta J., Lirenman D.S., Hardman P., Sams V.R., Risdon A.R. and Woolf A.S. (1996b). Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int. 49, 135-146.
32. Winyard P.J.D., Bao Q., Hughes R.C and Woolf A.S. (1997). Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. J. Am. Soc. Nephrol. 8, 1647-1657.
33. Woolf A.S. (1995). Clinical impact and biological basis of kidney malformations. Sem. Nephrol. 15, 361-372.
34. Woolf A.S., Kolatsi-Joannou M., Hardman P., Andermarcher E., Moorby C., Fine L.G., Jat P.S., Noble M.D and Gherardi E. (1995). Roles of hepatocyte growth factor/scatter factor and the met receptor in early development of the metanephros. J. Cell Biol. 128, 171-184.
35. Woolf A.S. and Cale C.M. (1997). Roles of growth factors in renal development. Curr. Opin. Nephrol. Hypertens. 6, 10-14.
36. Woolf A.S. and Winyard P.J.D. (1998). Advances in the cell biology and genetics of human kidney malformations. J. Am. Soc. Neprol. 9, 1114-1125.